Ranibizumab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7502 publications
Long-Term Outcomes and Predictors of Response to Anti-VEGF Therapy for Diabetic Macular Edema in Clinical Practice.
Journal: Journal of visualized experiments : JoVE
Published: June 22, 2026
Clinical Outcomes of Anti-VEGF Monotherapy Versus Combination Therapy in Diabetic Macular Edema: A Retrospective Cohort Study.
Journal: Journal of visualized experiments : JoVE
Published: May 18, 2026
Real-world durability challenges with nAMD treatments and the potential promise of gene therapy.
Journal: Current medical research and opinion
Published: May 14, 2026
Faricimab for choroidal neovascular membrane secondary to choroidal osteoma: A case report.
Journal: The Journal of international medical research
Published: May 14, 2026
Cost analysis of aflibercept 8 mg versus other anti-VEGF agents
Journal: Vestnik oftalmologii
Published: April 28, 2026
Switching to the Biosimilar Ranibizumab-nuna for the Intravitreal Treatment of Retinal Diseases - a Real-World Study.
Journal: Klinische Monatsblatter fur Augenheilkunde
Published: April 20, 2026
Longitudinal Tracking of Photoreceptor Integrity in Neovascular AMD: Early Restoration Predicts 24-Month Structural and Visual Outcomes.
Journal: Investigative ophthalmology & visual science
Published: April 17, 2026
Signals of Drug-Related Retinal Fibrosis: Findings From a 20-Year Disproportionality Analysis of Global Spontaneous Reports.
Journal: Translational vision science & technology
Published: April 13, 2026
Visual Acuity and Durability Outcomes of Faricimab Compared With Other Anti-vascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Diabetic Macular Edema.
Journal: Journal of vitreoretinal diseases
Published: April 13, 2026
Visual Acuity and Durability Outcomes of Faricimab Compared With Other Antivascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Neovascular Age-Related Macular Degeneration.
Journal: Journal of vitreoretinal diseases
Published: April 13, 2026
Correction to "Urinary Biomarkers and Serum VEGF in Preterm Infants With Retinopathy of Prematurity Treated With Ranibizumab".
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: April 09, 2026
Last Updated: 06/30/2026